Pregabalin reduces the release of synaptic vesicles from cultured hippocampal neurons.
about
New molecular targets for antiepileptic drugs: alpha(2)delta, SV2A, and K(v)7/KCNQ/M potassium channelsPharmacological disruption of calcium channel trafficking by the alpha2delta ligand gabapentinPharmacological Approaches for Treatment-resistant Bipolar DisorderNeuropathic Pain due to Small Fiber Neuropathy in Aging: Current Management and Future ProspectsA selective review of glutamate pharmacological therapy in obsessive-compulsive and related disorders.Pregabalin modulation of neurotransmitter release is mediated by change in intrinsic activation/inactivation properties of ca(v)2.1 calcium channels.Elevated insular glutamate in fibromyalgia is associated with experimental painComparative effects of chronic administrations of gabapentin, pregabalin and baclofen on rat memory using object recognition test.Pregabalin: latest safety evidence and clinical implications for the management of neuropathic pain.Pregabalin in acute and chronic pain.A comparative study of pre-operative oral clonidine and pregabalin on post-operative analgesia after spinal anesthesia.Impact of a stepwise protocol for treating pain on pain intensity in nursing home patients with dementia: a cluster randomized trial.Double-blind, placebo-controlled study of HGF gene therapy in diabetic neuropathy.Gabapentin inhibits catecholamine release from adrenal chromaffin cellsEffect of Pregabalin on Cardiovascular Responses to Exercise and Postexercise Pain and Fatigue in Fibromyalgia: A Randomized, Double-Blind, Crossover Pilot Study.Computational models of neuronal biophysics and the characterization of potential neuropharmacological targets.In vivo imaging reveals that pregabalin inhibits cortical spreading depression and propagation to subcortical brain structures.Drug safety evaluation of pregabalin.Comparison of oral absorption models for pregabalin: usefulness of transit compartment model.Pregabalin antagonizes copper-induced toxicity in the brain: in vitro and in vivo studies.Felbamate but not phenytoin or gabapentin reduces glutamate release by blocking presynaptic NMDA receptors in the entorhinal cortex.The Contribution of NMDA Receptors in Antinociceptive Effect of Pregabalin: Comparison of Two Models of Pain Assessment.An effective pharmacological management of postburn hypertrophic scar painDisturbance of consciousness and involuntary movements caused by pregabalin.Exposure-response analyses of the effects of pregabalin in patients with fibromyalgia using daily pain scores and patient global impression of change.The pH probe CypHer™5E is effectively quenched by FM dyes.POSH participates in epileptogenesis by increasing the surface expression of the NMDA receptor: a promising therapeutic target for epilepsy.GABA-from Inhibition to Cognition: Emerging Concepts.A rat model of FOLFOX-induced neuropathy: effects of oral dimiracetam in comparison with duloxetine and pregabalin.Effects of antiepileptic drugs on GABA release from rat and human neocortical synaptosomes.The antidepressant fluoxetine mobilizes vesicles to the recycling pool of rat hippocampal synapses during high activity.Levetiracetam has an activity-dependent effect on inhibitory transmission.
P2860
Q24654230-0ECBDA9C-30A8-4DF5-86B8-BB3C0DC2BEB3Q24656027-6E193DAB-5D0D-4823-90D4-B51D680F75A7Q26783002-56810B16-61F0-4051-8CB4-3F17E405A3EAQ26799409-C8A94880-B6F7-4455-9CEB-9004A6A9EA51Q28082048-2C4CB2FA-3DD0-420C-AE0D-AC77D9DED864Q30498941-83E89041-0A1E-4925-BCCF-37F2DE9C4C8FQ33684257-C15FFF76-304F-4980-A518-26E3E2A0E67DQ33782304-0291F8C8-34F1-4300-98FB-856E51A1E27AQ33949565-4DD91653-7F9A-4066-ADD1-C2697438C89AQ34214071-EF2C29CF-5423-4522-93DF-E093E9D599B1Q34237071-D5D1FB03-7AD1-4CBC-B1B3-26E4E1E65837Q34511242-6972A5D6-809D-41F5-B9F8-30BDFDA6D87CQ35619182-A323298F-B6D8-4155-B815-7733E26B7C84Q35925069-0B2DC3B7-0C8E-4B39-B4E6-72AD357EC8B9Q36454964-BC3265AE-CD91-44CE-A8C6-F2227D86782FQ36576250-2F5767E7-EB5D-4227-8A96-805DE303A2E0Q37682393-A001F6E4-647E-482E-BC4A-C9921E84BF10Q37999052-07A1D01D-CDDF-4B81-9E35-9534A2FBCACFQ39085683-845921B3-9228-4D03-987A-FB0A695FB894Q39613169-64B0E811-5A57-43FF-8484-DB22333E1EBEQ41190061-AFA1F647-E326-448C-8A23-7715974DFFDAQ41438108-63E5E069-9E33-491F-96C8-B680DFCDBC45Q41961591-60A9AF38-13BF-428E-92CF-BB7EFCA2412BQ42265954-A28DF454-345F-4954-AB98-4AAE5CF4A603Q43112877-2196EC85-B975-4FC3-BA5F-2A46255B369BQ45203482-6CD96159-6BFA-4634-9E09-D3A6DC3D799DQ47604309-28FD3769-519A-45E5-94D5-71276E604619Q47893077-93E62198-38CE-4597-AF4F-FC039EB8DB54Q48194389-BF781F46-D0C9-4B23-BF6B-20B19EDC7EB7Q48267237-443EC012-C9D5-45F4-A867-D5B49E19D760Q48404937-5EC09E96-40D0-4649-9741-C9A355B1B47DQ48682921-A7CF17C2-EB83-40FF-A04A-3ED95BD3738E
P2860
Pregabalin reduces the release of synaptic vesicles from cultured hippocampal neurons.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Pregabalin reduces the release of synaptic vesicles from cultured hippocampal neurons.
@en
Pregabalin reduces the release of synaptic vesicles from cultured hippocampal neurons.
@nl
type
label
Pregabalin reduces the release of synaptic vesicles from cultured hippocampal neurons.
@en
Pregabalin reduces the release of synaptic vesicles from cultured hippocampal neurons.
@nl
prefLabel
Pregabalin reduces the release of synaptic vesicles from cultured hippocampal neurons.
@en
Pregabalin reduces the release of synaptic vesicles from cultured hippocampal neurons.
@nl
P356
P1476
Pregabalin reduces the release of synaptic vesicles from cultured hippocampal neurons.
@en
P2093
Charles P Taylor
Stephen J Smith
P304
P356
10.1124/MOL.106.023309
P577
2006-04-26T00:00:00Z